TVARDI THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
TVARDI THERAPEUTICS, INC. (TVRD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $10.77 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2025-03-11
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $10.77M, a 15.94% decline from fiscal 2023.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $12.81M, a 9.51% decline from fiscal 2022.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $14.16M, a 10.21% increase from fiscal 2021.
- TVARDI THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2021 was $12.84M, a 0.20% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2024-12-31 | $10.77M 10-K · filed 2025-03-11 |
| 2023-12-31 | $12.81M 10-K · filed 2025-03-11 |
| 2022-12-31 | $14.16M 10-K · filed 2025-03-11 |
| 2021-12-31 | $12.84M 10-K · filed 2024-03-06 |
| 2020-12-31 | $12.82M 10-K · filed 2023-03-06 |
| 2019-12-31 | $10.07M 10-K · filed 2022-03-01 |
| 2018-12-31 | $9.02M 10-K · filed 2021-02-25 |
| 2017-12-31 | $5.30M 10-K · filed 2020-02-27 |
| 2016-12-31 | $3.59M 10-K · filed 2019-03-12 |
| 2015-12-31 | $2.49M 10-K · filed 2018-03-15 |
| 2014-12-31 | $393.00K 10-K · filed 2017-03-10 |
| 2013-12-31 | $75.00K 10-K · filed 2016-03-11 |
| 2012-12-31 | $65.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |